C型肝炎ウイルス感染に対して有用な製剤

Japanese Patent JP2006514094

A

The present invention relates generally to chemical compounds and substances which are effective against Hepatitis C virus (HCV) infections. Moreover, the present invention relates to compositions comprising said compounds and/or substances, to methods for preventing HCV infections as well use of the compounds and/or substances for the preparation of compositions useful for the prophylaxis and/or treatment of HCV infections. Useful compounds and substances according to the invention are selenium, selenium salts, Vitamin D₃ and retinoids, like all trans retinoic acid and salts thereof, C₁-C alkyl amides of all trans retinoic acid and salts thereof, C₁-C₁₀ alkyl esters of all trans retinoic acid and salts thereof, 9-cis retinoic acid and salts thereof, C₁-C₁₀ alkyl amides of 9-cis retinoic acid and salts thereof, C₁-C₁₀ alkyl esters of 9-cis retinoic acid and salts thereof, (E)-4-[2(5,6,7,8-tetrahydro-5,5,8,8-tetra methyl-2-naphthalenyl-1-propenyl)benzoic acid (TTNPB), (4-[5,6,7,8-tetrahydro5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic acid (AM-580), N-(4-hydroxyphenyl)retinamide (4-HPR), and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN).

JP2008189605	OSTEOBLAST DIFFERENTIATION PROMOTER
WO/2022/159506	DEUTERATED CANNABIDIOL COMPOUNDS

Helget, Thomas
Creble belt

JP2004570683A

April 27, 2006

December 01, 2003

Click for automatic bibliography generation  

GoePetse Biotech Akchen Gezel Shaft

A61K31/045; A61K9/20; A61K9/48; A61K31/00; A61K31/16; A61K31/192; A61K31/203; A61K31/232; A61K31/573; A61K33/04; A61K38/21; A61P31/04; A61P31/14

JPH08504799A

1996-05-21

WO2002066022A1	2002-08-29
WO2002084294A2	2002-10-24

Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Masaya Nishiyama

Previous Patent: Ｘａ因子阻害剤としてのイミダゾール誘導体

Next Patent: ピラゾール誘導体